US 11541070
Administration of an anti-activin-A compound to a subject
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 11541070 (Administration of an anti-activin-A compound to a subject) held by Atara Biotherapeutics, Inc. expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Atara Biotherapeutics, Inc.
- Grant date
- Tue Jan 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61K31/704, A61K31/7068